StockWatch
·

Ocugen, Inc.

Ticker: 1372299

values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-25.96-8.888.2125.29Q2 FY2020Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q1 FY2026

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q2 FY2020Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q1 FY2026
PeriodQ1 FY2026Q3 FY2025Q2 FY2025Q1 FY2025Q3 FY2024Q2 FY2024Q1 FY2024Q2 FY2020
INCOME
Revenue1.53-12.6%1.75+27.7%1.37-7.4%1.48+29.8%1.14+0.0%1.14+12.9%1.01+2425.0%0.04
Total Income1.53-12.6%1.75+27.7%1.37-7.4%1.48+29.8%1.14+0.0%1.14+12.9%1.01+2425.0%0.04
EXPENSES
Expenditure19.37-0.1%19.38+27.8%15.17-5.1%15.98+11.0%14.39-13.3%16.59+25.4%13.23+288.0%3.41
PROFIT
Net Profit-19.18+4.3%-20.05-36.0%-14.74+4.0%-15.35-18.4%-12.97+15.1%-15.28-28.2%-11.92-230.2%-3.61
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.06-0.04+20.0%-0.05+73.7%-0.19

Corporate Events

Board MeetingOCGN
2026
11Jun

Board Meeting

2026 Annual Meeting of Stockholders voting results, includin…

SEC Filing
Board MeetingOCGN
2026
3Jun

Board Meeting

Chief Accounting Officer transition: Ramesh Ramachandran res…

SEC Filing
Board MeetingOCGN
2026
8May

Board Meeting

Chief Medical Officer Transition — Huma Qamar separated as C…

SEC Filing
Board MeetingOCGN
2026
5May

Board Meeting

First Quarter 2026 Financial Results and Business Update Con…

SEC Filing